Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (2987)	7/11/1998 10:27:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 5402

RUMORS about the competition - alliance To: 993racer (291 ) From: Bob Barels (Trial Member) Friday, Jul 10 1998 12:54AM ET Reply # of 292 Not any employee but someone with a much higher ranking than a department manager. He believes that both products will be approved (I don't bother with IMAGENT because I don't think is very significant)and believe it or not he did not sell his stake even when the stock hit $42 several years ago. Tough break! As for me being negative it is because I got tired waiting all these years. The company keeps investors in the dark (whatever happened to LIQUIVENT?)and everyone else has failed in the blood substitute area. This means it might take years to get a product in that area and maybe nothing will work. One thing I was told -I don't know if I should laugh or take it seriously- is that there is a lot of money behind the blood market (blood mafia etc.) and many people do not want to see a blood substitute product being approved. For someone who believes that the product(s) will work this is a great price to get in. As for myself, I bought recently at $4.5 for trading purposes hoping that an announcement for a new partner (since people don't like the word sucker) and/or start of Phase III is imminent.That should send the stock back to $8. Thanks regards, BOB